September 28, 2020

Richard Becker, MD, and Duncan Hite, MD, both professors in the UC College of Medicine and UC Health physicians, spoke with WVXU reporter Ann Thompson about a phase 2 clinical trial underway at UC/UC Health to determine the safety and efficacy of the drug razuprotafib in treating COVID-19 patients. UC is one of 20 sites across the nation participating in the trial.

September 28, 2020

Dr. Jennifer Forrester of the UC College of Medicine Division of Infectious Diseases was featured in an article on Cincinnati.com about ways to stay safe while observing Halloween during the COVID-19 pandemic.

September 29, 2020

UC political scientist David Niven speaks to the pre-debate topic of Trump's personal tax history.

September 29, 2020

About 34 million Americans are diagnosed with diabetes. It is the seventh leading cause of death in our nation. Individuals with uncontrolled diabetes are among the groups most at risk of experiencing severe reactions to COVID-19. The pandemic has forced businesses to close or lay off employees impacting the ability of families to make their incomes cover housing, food and medicine. How can families continue to make healthy options when some are limited to shopping at a nearby dollar store?

September 29, 2020

UC College of Law Professor Ronna Greff Schneider discusses the complex issue of students' rights versus school rules.

September 29, 2020

The city of Cincinnati recently banned the use of single-use plastic bags at businesses beginning in January. The Saudi Arabian Student Association at the University of Cincinnati attempted to break a world record for the largest mosaic using reusable grocery bags.

September 30, 2020

Drug Target Review discusses findings of a study looking at the use of a naturally occurring lipid to prevent COVID-19 infection.

September 30, 2020

Hundreds participated in virtual Bearcat debate watch party and got the chance to react to the candidates in real time.

September 30, 2020

Richard Becker, MD, director of the UC Heart, Lung and Vascular Institute, was interviewed by a reporter for Contagion Live about a new phase 2 clinical trial UC and UC Health are conducting using the drug razuprotafib, to lessen inflammation of the blood vessels in COVID-19 patients. Razuprotafib activates a key pathway for stabilizing blood vessels in the lungs and may prevent or treat respiratory distress in COVID-19 patients.

October 1, 2020

The University of Cincinnati’s School of Planning is stepping up to remind us that cities aren’t the source of America’s current predicaments, but instead can be the ultimate solution to a healthier, more sustainable, and more equitable society.